InChI=1S/C22H27NO2/c1- 4- 22(24) 10- 8- 18- 16- 6- 5- 15- 11- 19- 14(13- 23- 25- 19) 12- 20(15,2) 17(16) 7- 9- 21(18,22) 3/h1,11,13,16- 18,24H,5- 10,12H2,2- 3H3/t16- ,17+,18+,20+,21+,22+/m1/s1 |
POZRVZJJTULAOH-LHZXLZLDSA-N |
[H][C@@]12CCC3=Cc4oncc4C[C@]3(C)[C@@]1([H])CC[C@@]1(C)[C@@]2([H])CC[C@@]1(O)C#C |
|
estrogen antagonist
A compound which inhibits or antagonises the biosynthesis or actions of estrogens.
|
|
anti-estrogen
A drug which acts to reduce estrogenic activity in the body, either by reducing the amount of estrogen or by reducing the activity of whatever estrogen is present.
estrogen antagonist
A compound which inhibits or antagonises the biosynthesis or actions of estrogens.
geroprotector
Any compound that supports healthy aging, slows the biological aging process, or extends lifespan.
|
|
View more via ChEBI Ontology
[1,2]oxazolo[4',5':2,3]-17α-pregn-4-en-20-yn-17-ol
|
danazol
|
KEGG DRUG
|
danazolum
|
ChemIDplus
|
Cyclomen
|
DrugBank
|
Danocrine
|
DrugBank
|
26436
|
ChemSpider
|
779
|
DrugCentral
|
D00289
|
KEGG DRUG
|
Danazol
|
Wikipedia
|
DB01406
|
DrugBank
|
GB905844
|
Patent
|
US3135743
|
Patent
|
View more database links |
17230-88-5
|
CAS Registry Number
|
ChemIDplus
|
4851114
|
Beilstein Registry Number
|
Beilstein
|
17929794
|
PubMed citation
|
ChEMBL
|
18834112
|
PubMed citation
|
ChEMBL
|
24134630
|
PubMed citation
|
Europe PMC
|
27626530
|
PubMed citation
|
Europe PMC
|
34462405
|
PubMed citation
|
Europe PMC
|
|